rs897083
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005048.4(PTH2R):c.982-3701A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.798 in 152,154 control chromosomes in the GnomAD database, including 48,792 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.80 ( 48792 hom., cov: 32)
Consequence
PTH2R
NM_005048.4 intron
NM_005048.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.82
Publications
7 publications found
Genes affected
PTH2R (HGNC:9609): (parathyroid hormone 2 receptor) The protein encoded by this gene is a member of the G-protein coupled receptor 2 family. This protein is a receptor for parathyroid hormone (PTH). This receptor is more selective in ligand recognition and has a more specific tissue distribution compared to parathyroid hormone receptor 1 (PTHR1). It is activated only by PTH and not by parathyroid hormone-like hormone (PTHLH) and is particularly abundant in brain and pancreas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTH2R | ENST00000272847.7 | c.982-3701A>G | intron_variant | Intron 9 of 12 | 1 | NM_005048.4 | ENSP00000272847.2 | |||
| PTH2R | ENST00000617735.4 | c.649-3701A>G | intron_variant | Intron 9 of 12 | 2 | ENSP00000482485.1 | ||||
| ENSG00000231896 | ENST00000424628.1 | n.103+7417A>G | intron_variant | Intron 1 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.798 AC: 121265AN: 152036Hom.: 48751 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
121265
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.798 AC: 121366AN: 152154Hom.: 48792 Cov.: 32 AF XY: 0.797 AC XY: 59267AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
121366
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
59267
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
35461
AN:
41520
American (AMR)
AF:
AC:
12405
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
2650
AN:
3470
East Asian (EAS)
AF:
AC:
2701
AN:
5164
South Asian (SAS)
AF:
AC:
3686
AN:
4820
European-Finnish (FIN)
AF:
AC:
8409
AN:
10576
Middle Eastern (MID)
AF:
AC:
224
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53472
AN:
68002
Other (OTH)
AF:
AC:
1656
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1237
2473
3710
4946
6183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2361
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.